← back to search

Sahar Salehi

Karolinska University Hospital · SE
Area of research
Oncology · Obstetrics and Gynecology
Research interest
Research interests include CAR-T cell therapy research, Endometrial and Cervical Cancer Treatments, Monoclonal and Polyclonal Antibodies Research, and Viral Infectious Diseases and Gene Expression in Insects.
h-index
16
citations
975
works
138
NIH funding
primary concept
email

Recent publications

TRUST: Trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7).
Journal of Clinical Oncology 2025cited by 36position: middledoi
Adaptive NK Cells Exhibit Tumor-Specific Immune Memory and Cytotoxicity in Ovarian Cancer
Cancer Immunology Research 2025cited by 14position: middledoi
Complications and recurrence after pelvic exenteration for gynecologic malignancies: Analysis of surgical complications from the COREPEX study
International Journal of Gynecological Cancer 2025cited by 1position: middledoi
The extracellular matrix – immune microenvironment crosstalk in cancer therapy: Challenges and opportunities
Matrix Biology 2023cited by 31position: middledoi
The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients
npj Precision Oncology 2023cited by 26position: middledoi
Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a subanalysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study
American Journal of Obstetrics and Gynecology 2023cited by 16position: middledoi
Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)—the final step towards a paradigm shift in surgical staging
European Journal of Cancer 2019cited by 237position: middledoi
Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial
International Journal of Gynecological Cancer 2019cited by 150position: lastdoi
Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic lymphadenectomy in women with high-risk endometrial cancer: A randomised controlled trial
European Journal of Cancer 2017cited by 64position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Kaisa Lehti · Norwegian University of Science and Technology3 papers (2023–2025)Henrik Falconer · Karolinska University Hospital3 papers (2017–2019)Okan Gultekin · Karolinska Institutet2 papers (2023–2025)Dhifaf Sarhan · Karolinska Institutet2 papers (2023–2025)Jan Persson · Lund University2 papers (2019–2019)Joseph W. Carlson · City Of Hope National Medical Center2 papers (2017–2023)Francesco Raspagliesi · University of Milan1 papers (2025–2025)Pernille Tine Jensen · Aarhus University1 papers (2019–2019)Jalid Sehouli · SLK-Kliniken Heilbronn1 papers (2025–2025)Kolbrún Pálsdóttir · Karolinska Institutet1 papers (2019–2019)Christina Fotopoulou · Imperial College London1 papers (2025–2025)Shiyong Neo · Agency for Science, Technology and Research1 papers (2025–2025)Olina Lind · Science for Life Laboratory1 papers (2023–2023)Ramanuj DasGupta · Agency for Science, Technology and Research1 papers (2025–2025)Giovanni Aletti · Charité - Universitätsmedizin Berlin1 papers (2025–2025)Lena Wijk · Virginia Commonwealth University1 papers (2019–2019) · 1 papers (2019–2019)Frédéric Guyon · Aristotle University of Thessaloniki1 papers (2025–2025)Florian Heitz · Erasmus MC Cancer Institute1 papers (2025–2025)Emma Åkerlund · Science for Life Laboratory1 papers (2023–2023)